This Upcoming Event Could Affect Sarepta Therapeutics Investors By: Benzinga via Benzinga March 18, 2015 at 14:09 PM EDT Credit Suisse commented on Sarepta Therapeutics Inc (NASDAQ: SRPT) ahead of an FDA workshop on Friday titled "Measuring ... Read More >> Related Stocks: Sarepta Therapeutics